Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 176   

Articles published

PFE 35.27 -0.09 (-0.25%)
price chart
Pfizer Inc. (PFE) Q1FY15 Earnings Preview: What You Need To Know
Pfizer Inc. (NYSE:PFE) is scheduled to release its first-quarter fiscal 2015 (1QFY15) earnings report before market opens on April 28.
Pfizer Earnings Preview: 2 Ways to Trade PFE Stock  Investorplace.com
Pfizer Inc. to Issue Quarterly Dividend of $0.28 (PFE)  The Legacy
Pfizer Inc. (PFE) Stock Update: Healthy Cancer Drug Pipeline Promises Strong ...
Pfizer Inc. (NYSE:PFE) has had quite an eventful month and the company's stock has gained as much as 1.87% in the past 30 days.
Pfizer's Once And Future Deals  Seeking Alpha
Pfizer Lifted to Hold at Vetr Inc. (PFE)  Dakota Financial News
Pfizer Inc. (PFE) Wins FDA Breakthrough Therapy Designation For Lung Cancer ...
Pfizer Inc. (NYSE:PFE) has yet another victory to add to its long list of successes in the healthcare sector. Its lung cancer drug Xalkori has been granted "Breakthrough Therapy Designation" by the US Food and Drug Administration (FDA) for the ...
Pfizer Inc. (NYSE:PFE) Releases XALKORI Got Breakthrough Therapy ...  StreetWise Report
Pfizer's Xalkori wins breakthrough status  theday.com
Pfizer Inc. (PFE), Anthem Inc (ANTM), Aetna Inc (AET): Swedish Fund ...
Anders Hallberg and Carl Bennet's healthcare-focused fund, Healthinvest Partners AB, recently disclosed its equity holdings in a 13F filing with the Securities and Exchange Commission.
Pfizer Inc. (PFE) And Provectus Biopharmaceuticals Get US Patent For Cancer ...
Pfizer Inc. (NYSE:PFE) and Provectus Biopharmaceuticals Inc (NYSEMKT:PVCT) today received approval from the US Patent Office for a joint patent application filed by the two companies for their investigational cancer drug, PV-10.
Pfizer and Provectus Biopharmaceuticals Receive Patent Allowance for Use of ...  MarketWatch
Pfizer Inc. (PFE) Victorious In First Trial Over Zoloft Birth-Defect Claims
Pfizer Inc. (NYSE:PFE) ended the past week on a positive note as a court ruled that the company's antidepressant Zoloft did not cause birth defects in children born to mothers who took the pill during pregnancy.
Pfizer Wins First of 1000 Suits Claiming Antidepressant Zoloft Link to Birth ...  Insurance Journal
Pfizer Jury Told Zoloft Risks Known But Hidden From Patients  Bloomberg
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the August ...
Why Some Pfizer, Inc. Investors Are Kicking Themselves Now
Shareholders of Pfizer (NYSE: PFE ) are no doubt pleased with 2015 so far. The big pharma stock is up 12% year-to-date, easily beating the performance of the S&P 500 index.
Pfizer Stock Could Have Higher Prices In Store, But Will It Pull Back First?  Benzinga
Are Investors Betting On Pfizer Inc. Coming Back For AstraZeneca plc?
AstraZeneca is currently valued at 4,851p a share, which is in line with the level it recorded in early May 2014, when investors were eager to bet on a successful outcome for Pfizer's proposed offer. By late May, however, Astra had rejected Pfizer's ...
Pfizer Accused of Knowing Zoloft Posed Birth-Defect Risk
Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
Pfizer Inc. Accused Of Withholding Information On Risks Associated With ...  Bidness ETC
Pharmalot�Pharmalittle�Good Morning: We're Catching up on Eisai, HepC ...  Wall Street Journal (blog)